Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on
LGI1
cortical metabolism
encephalitis
fluorodeoxyglucose
positron emission tomography
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
11
2022
accepted:
09
03
2023
medline:
18
4
2023
entrez:
17
4
2023
pubmed:
18
4
2023
Statut:
epublish
Résumé
A general glucose metabolism pattern is observed in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis; however, it is unclear whether further subregional metabolic differences exist. Therefore, the present study aimed to conduct an in-depth exploration of the features of glucose metabolism within specific brain areas using This retrospective study enrolled thirteen patients confirmed with LGI1 antibody encephalitis who were admitted to Beijing Tiantan Hospital from June 2021 to September 2022. All patients underwent Significant metabolic changes in at least one brain region in 11 out of 13 patients (84.6%) were revealed by semi-quantitative analysis ( An asymmetric
Identifiants
pubmed: 37064193
doi: 10.3389/fneur.2023.1100760
pmc: PMC10102654
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1100760Informations de copyright
Copyright © 2023 Wang, Zhao, Yuan, Chen, Wang and Ai.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor JL declared a shared affiliation, though no other collaboration, with authors KW, XZ, LY, QC, QW, and LA at the time of the review.
Références
Brain. 2016 Apr;139(Pt 4):1079-93
pubmed: 26945884
Brain Struct Funct. 2019 Dec;224(9):3001-3018
pubmed: 31451898
J Neurosci. 2009 Nov 25;29(47):14980-6
pubmed: 19940193
Neuroscience. 2015 Nov 19;309:68-83
pubmed: 26012492
Diagnostics (Basel). 2020 May 29;10(6):
pubmed: 32486044
J Neurosci. 2019 Apr 3;39(14):2698-2708
pubmed: 30700532
Front Immunol. 2015 Jan 22;6:1
pubmed: 25657648
BMC Neurosci. 2011 May 13;12:43
pubmed: 21569517
J Neuroinflammation. 2018 Sep 25;15(1):279
pubmed: 30253786
Neurology. 2007 Sep 18;69(12):1298-300
pubmed: 17875918
Front Neurol. 2022 May 30;13:812439
pubmed: 35711267
J Neuroimmunol. 2013 Dec 15;265(1-2):75-81
pubmed: 24176648
PLoS One. 2013;8(2):e56543
pubmed: 23441202
Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e352
pubmed: 28567435
Brain. 2012 May;135(Pt 5):1622-38
pubmed: 22539258
Front Immunol. 2021 Sep 20;12:672846
pubmed: 34616389
Brain. 2006 Mar;129(Pt 3):564-83
pubmed: 16399806
Neurol Neuroimmunol Neuroinflamm. 2022 Jan 28;9(2):
pubmed: 35091466
Neuron. 2017 Apr 19;94(2):249-263
pubmed: 28426959
Neuroradiology. 2018 Feb;60(2):189-198
pubmed: 29255919
Lancet Neurol. 2010 Aug;9(8):776-85
pubmed: 20580615
Clin Nucl Med. 2015 Feb;40(2):156-8
pubmed: 25140541
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
CMAJ. 2019 May 13;191(19):E529-E534
pubmed: 31085562
Front Neurol. 2020 Jun 05;11:418
pubmed: 32581996
Annu Rev Neurosci. 2001;24:167-202
pubmed: 11283309
Brain. 2010 Sep;133(9):2734-48
pubmed: 20663977
Neurol Sci. 2021 Aug;42(8):3423-3425
pubmed: 33763811
Brain Behav. 2020 Oct;10(10):e01793
pubmed: 32783406
Neuroscience. 2014 Sep 26;277:577-83
pubmed: 25086308
Dement Neuropsychol. 2016 Oct-Dec;10(4):351-357
pubmed: 29213481
J Mol Neurosci. 2008 Jul;35(3):323-9
pubmed: 18563303